DOCSLIB.ORG

October 27, 2020 PROFESSOR STEPHEN HEDRICK, Professor

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
October 27, 2020 PROFESSOR STEPHEN HEDRICK, Professor ACADEMIC SENATE: SAN DIEGO DIVISION, 0002 UCSD, LA JOLLA, CA 92093-0002 (858) 534-3640 FAX (858) 534-4528 October 27, 2020 PROFESSOR STEPHEN HEDRICK, Professor Division of Biological Sciences PROFESSOR MITCHELL KRONENBERG, Professor Division of Biological Sciences PROFESSOR KIT POGLIANO, Dean Division of Biological Sciences PROFESSOR ASA GUSTAFSSON, Chair Biomedical Sciences Graduate Program SUBJECT: Proposal to establish PhD Specialization in Immunology At its October 12, 2020 meeting, the Graduate Council approved the proposal to establish a PhD specialization in Immunology, to be offered to students in the Division of Biological Sciences and the Biomedical Sciences Graduate Program. The Council supports the creation of the following degree titles: PhD in Biology with a Specialization in Immunology PhD in Biomedical Sciences with a Specialization in Immunology Final approval from the Representative Assembly is required to establish the new degree titles. Prior to forwarding the proposal for placement on an upcoming Representative Assembly agenda, please provide an addendum to the proposal that clarifies the requirements for doctoral committee membership for the specialization to Senate Associate Director Lori Hullings ([email protected]). Rather than provide links to the committee membership for each program, please clearly state the committee membership for a student in the Immunology specialization. It would be helpful to include if a co-chair is required if the Immunology faculty advisor is not from the student’s home department and who is eligible to serve as the tenured outside member. If approved, the new degree titles will be available to students in Fall Quarter 2021. Sincerely, Lynn Russell, Chair Graduate Council cc: M. Allen J. Antony S. Constable S. Garfin T. Javidi C. Lyons R. Rodriguez Hullings, Lori From: Hullings, Lori Sent: Monday, November 2, 2020 9:20 AM To: Hedrick, Stephen Cc: Talia Delamare; Mitchell Kronenberg; Antony, James; Allen, Mary; Russell, Lynn; Pogliano, Kit; Gustafsson, Asa; Constable, Steven; Javidi, Tara; Rodriguez, Ray Subject: PhD Specialization in Immunology: Addendum to doctoral committee requirements Dear Professor Hedrick, The Graduate Council approved the addendum (copied below) clarifying the doctoral committee requirements for the PhD Specialization in Immunology with one modification (underlined in the text below). I will add this to the proposal. Thank you for quickly responding to the Graduate Council’s request. Best, Lori The composition of the Doctoral Committee for students in the PhD specialization in Immunology will be enforced in accordance with University and home department regulations. The committee must have a minimum of five members and adhere to the requirements established by Biological Sciences or Biomedical Sciences. The chair of the committee will be a member of the respective graduate programs, either Biological Sciences or Biomedical Sciences. We expect the chair of the committee should also be a member of the Program in Immunology faculty; however, the directors will consider a petition for an outside mentor subject to the same criteria used for Program membership: Appointment at UC San Diego; an interest in some field of study related to immunology; and stable funding consistent with support of a pre-doctoral fellow’s research. The dissertation committee will be chosen by the dissertation advisor and the student, consistent with the requirements set forth by the two graduate programs and the Dean of Graduate Division. We recommend that two faculty members affiliated with the Program in Immunology be included in the committee, though this is not an absolute requirement. From: Hedrick, Stephen Sent: Friday, October 30, 2020 12:07 PM To: Hullings, Lori <[email protected]> Cc: Talia Delamare <[email protected]>; Mitchell Kronenberg <[email protected]> Subject: Addendum to doctoral committee requirements Dear Lori: Please find an attached addendum or clarification of our requirements for a doctoral committee in the Specialization in Immunology. If you have any further questions, please do not hesitate to contact me at one of the coordinates listed below. Best regards, Steve 1 UC San Diego Administrative Cover Sheet: New Academic Degree Programs/Remote Courses DOCUMENT TYPE AND BRIEF DESCRIPTION: Proposal for a Specialization in Immunology within the Biological and Biomedical Sciences PhD programs. HEAD OF INITIATING OFFICE: Stephen Hedrick, PhD Distinguished Professor Molecular Biology and [email protected] Cell & Mol. Medicine Signature: RETURN DOCUMENT TO: Talia Delamare 858-752-6548 [email protected] Mail Code ROUTING TITLE DATE IN ORDER SIGNATURE DATE OUT Executive Vice Chancellor - Academic Affairs 10 7/23/20 Vice Chancellor - Health Sciences Vice Chancellor - Marine Sciences Office of Resource Administration: Steve Ross Steven Ross 9 Steven Ross (Jun 16, 2020 17:17 PDT) Office of Resource Administration: Name, Title Dean of Undergraduate Education Dean of the Graduate Division - Mary Allen in case 8 of Dean Antony 7 Dean: Kit Pogliano - Biological Sciences STEVEN R GARFIN,MD 6 Dean: Steve Garfin - Biomedical Sciences STEVEN R GARFIN,MD (Jul 14, 2020 10:06 PDT) 5 Teaching + Learning Commons: Name, Title Department Chair: Name, Department 4 Department Chair: Name, Department 3 1 Other: Name, Title 1 Other: Name, Title Please refer to Procedures for Administrative Review of New Academic Programs and Remote Courses for appropriate routing details Ph.D. Degree in Biological or Biomedical Sciences with a Specialization in Immunology Program Information Doctor of Philosophy degree in Biological Sciences (BS) or Biomedical Sciences (BMS) with a specialization in Immunology Proposed Start Date 09/01/2020 Brief description of the program This proposed graduate study program will award a Ph.D. with a specialization in Immunology as part of graduate training in the UC San Diego BMS and BS graduate programs. Students will be accepted to one of these two programs, and they will satisfy all of the requirements of their chosen program. In addition, the specialization will promote an immersive educational experience in immunology that includes participation in immunology coursework, original research, seminars given by renowned speakers, biweekly research presentations by peers, a weekly journal club, and a yearly area-wide immunology conference. The specialization will be overseen by the Program in Immunology; a newly-established Center that represents a lasting partnership between UC San Diego and the La Jolla Institute for Immunology (LJI). It is composed of more than 70 world-class faculty members, with 23 from LJI, and the remainder from UC San Diego across campus departments and Health Sciences. The Ph.D. specialization in Immunology will blend existing and new courses designed to familiarize students with the program faculty and expose them to facilities and techniques that are widely used in the field. New courses include “Bioinformatics for Immunologists” that has been developed and “Immunological Basis of Disease” that is being planned and will be developed to complement courses currently given. The coursework is intended to provide a sound theoretical foundation to the broad aspects of immunology along with opportunities for sub-specialization. All necessary resources are in place to support this specialization. We propose to allow existing students to enroll in the specialization beginning Fall 2020 and to admit the first new class of students Fall 2021. Modality of the program On-Site Name of the institution’s two most closely related programs to the proposed program Immunology is presently an area of emphasis or track within the BMS program. Immunology thesis research is available to students in laboratories in the BS program; but without any designation that this is an area of interest. Anecdotal reports and interviews with present students indicate, however, that student applicants with an interest in immunology often do not target UC San Diego for graduate school. Number of new courses being required for this program “Bioinformatics for Immunologists” - This course has been approved by the Health Sciences Graduate Programs Education Committee (GPEC). Number of new faculty members required for this program: 0 Significant additional equipment or facilities needed for this program: None Significant additional financial resources needed: None Significant additional library/learning resources needed: None A proposal for an interdisciplinary Ph.D. Specialization in Immunology Supported by the As part of the graduate programs in the Biomedical Sciences (BMS) and the Division of Biological Sciences (BS) at UC San Diego Date of preparation: August 10, 2020 Contact Information Sheet Program Directors: Stephen M. Hedrick Mitchell Kronenberg Distinguished Professor President and Chief Scientific Officer Molecular Biology La Jolla Institute for Immunology Cellular and Molecular Medicine Adjunct Professor, Div. Biological Sciences University of California San Diego University of California San Diego [email protected] [email protected] 5121 Natural Sciences Building 9420 Athena Circle 9500 Gilman Drive La Jolla, CA 92037 La Jolla, CA 92093-0377 858-752-6540-office 858-534-6269-office 858-353-6702-mobile 858-353-1807-mobile Proposal for a Graduate Specialization in Immunology-UC San Diego Other Contacts: Lanisa Medina Talia Delamare cMAV Program Manager Project Manager, Executive Offices University of California, San
Load more

Recommended publications
  • Medical Leadership and Affiliate Providers
    Scripps Proton Therapy Center Medical Leadership and Affiliate Providers SCRIPPS HEALTH AND SCRIPPS CLINIC – Scripps Health provides clinical management services for Scripps Proton Therapy Center and Scripps Clinic oversees the center’s medical services. Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a nonprofit integrated health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 13,500 employees among its five acute-care hospital campuses, hospice and home health care services, and an ambulatory care network of physician offices and 26 outpatient centers and clinics. With more than 500 physicians and 50 medical and surgical specialties, Scripps Clinic provides care for a wide range of diseases and conditions at 13 locations across San Diego County. Recognized as a leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research, genomic medicine, wireless health care and graduate medical education. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges. Truven Health Analytics (formerly Thomson Reuters) has named Scripps one of the top five large health systems in the nation. Scripps is nationally recognized in six specialties by U.S. News & World Report, which places Scripps’ cardiovascular program among the top 20 in the country. Scripps has been consistently recognized by Fortune, Working Mother magazine and AARP as one of the best places in the nation to work. For more information, visit www.scripps.org. RADY CHILDREN’S HOSPITAL-SAN DIEGO – Rady Children’s Hospital-San Diego is an affiliate provider of pediatric care at Scripps Proton Therapy Center.
    [Show full text]
  • Speaker Bios
    Moores UCSD Cancer Center Industry/Academia Translational Oncology Symposium Speaker Bios David R. Bentley, D.Phil. Vice President & Chief Scientist, Illumina, Inc. David Bentley, Ph.D., is Chief Scientist for Illumina’s Sequencing business. His major research interest is the study of human sequence variation. He was previously Head of Human Genetics and founding member of the Board of Management at the Wellcome Trust Sanger Institute where he played leading roles in the Institute’s contribution to the human genome referencing sequence, the SNP Consortium and the International HapMap Project. Dr. Bentley earned a degree in Natural Sciences from the University of Cambridge, took a DPhil at the University of Oxford, and is currently a Fellow of the Academy of Medical Sciences. Clara D. Bloomfield, M.D. Distinguished University Professor William G. Pace III Professor of Cancer Research Cancer Scholar and Senior Advisor, Ohio State University Comprehensive Cancer Center and James Cancer Hospital and Solove Research Institute Education &Academic Appointments: 1968 M.D. U Chicago; 1973-80, Assistant, Associate Prof. of Medicine, U Minnesota (U. MN), Minneapolis, MN; 1980-89 Prof. of Medicine, Div. of Oncology, U.MN; 1989-97 Prof. of Medicine & Chief, Div. of Oncology, State University of NY at Buffalo; 1989-97 Chair, Department of Medicine, Roswell Park Cancer Institute (RPCI), Buffalo, NY; 1997-2001 Director, Div. of Hematology & Oncology, Department of Internal Medicine, The Ohio State University College of Medicine & Public Health (OSU COMPH), Columbus, OH; 1997- William G. Pace III Endowed Chair in Cancer Research & Prof, OSU; 1997-2003 Director, Comprehensive Cancer Center (CCC) & Deputy Director, James Cancer Hospital & Solove Research Institute (JCH), OSU; 2003- Cancer Scholar & Senior Advisor, OSUCCC & JCH; 2006- Distinguished University Prof.
    [Show full text]
  • VASDHS Psychology Internship Brochure
    2021-22 UCSD/VA PSYCHOLOGY INTERNSHIP TRAINING PROGRAM Department of Psychiatry University of California, San Diego VA San Diego Healthcare System Co-Directors Sandra Brown, Ph.D., ABPP Amy Jak, Ph.D. Applicant Manual Last updated September 2020 Dear Prospective Applicant, Thank you for your interest in the UCSD/VA Psychology Internship Training Program. In the following pages, you will find detailed information about our internship, including clinical training, didactic experiences, research opportunities, our faculty, and application instructions. Our program is based on the scientist-practitioner model. As such, we seek competitive applicants interested and experienced in both research and clinical practice, particularly those interested in academic careers. Clinical training and didactic experiences integrate cutting-edge evidence-based techniques with a foundation of established empirically-supported treatments and assessment. We also recognize the importance of diversity represented by our trainees and faculty, as well as in our patients. We encourage those of diverse backgrounds, in all the many ways that diversity is defined, to apply to our program. Our full-time internship has been accredited by APA since 1986 (Further information about accreditation of this program can be found at: Office of Program Consultation and Accreditation, American Psychological Association, 750 First Street, N.E., Washington, DC 20002-4242, Phone: (202) 336-5979, Fax: (202) 336-5978, Email: [email protected], Web: www.apa.org/ed/accreditation). For the 2021-2022 year, interns will earn an annual stipend of $29,212. Our competitive benefits, both for UCSD and for the VA, include health insurance, paid leave days, and paid holidays. The COVID-19 pandemic has led our faculty to implement multiple changes in our training program.
    [Show full text]
  • Revised January 2003
    Revised 9 June 2017 CURRICULUM VITAE NAME Anjana Rao OFFICE ADDRESS La Jolla Institute for Allergy & Immunology 9420 Athena Circle La Jolla, CA 92037 Telephone: (858) 952-7155/7161 FAX: (858) 752-6984 Email: [email protected] PLACE OF BIRTH Washington, D. C., USA EDUCATION 1970 B.Sc. Osmania University, Hyderabad, India 1972 M.Sc. Osmania University, Hyderabad, India (Physics) 1978 Ph.D. Harvard University, Cambridge, MA (Biophysics) POSTDOCTORAL TRAINING 1978-1979 Fellow in Medicine, Harvard Medical School 1979-1981 Fellow in Pathology, Harvard Medical School ACADEMIC APPOINTMENTS 1981-1984 Instructor in Pathology, Harvard Medical School 1984-1992 Assistant Professor of Pathology, Harvard Medical School 1993-1995 Associate Professor of Pathology, Harvard Medical School 1981-2009 Board of Tutors, Department of Biochemistry and Molecular Biology, Harvard University 1988-1995 Associate Head Tutor, Department of Biochemistry and Molecular Biology, Harvard University 1996-2010 Professor of Pathology, Harvard Medical School 1995-2011 Senior Investigator, Immune Disease Institute 2009-2011 Program in Cellular and Molecular Medicine, Children’s Hospital Boston 2010-present Professor, Division of Signaling and Gene Expression, La Jolla Institute (LJI) 2011-present Professor, Sanford Consortium for Regenerative Medicine, La Jolla 2011-present Affiliate faculty appointment, Department of Pharmacology, UCSD 2011-present Faculty member, Biomedical Sciences Graduate Program, UCSD 2011-present Health Sciences Immunity/Infection/Inflammation (Triple I), UCSD
    [Show full text]
  • SDSC Welcomes Halicioğlu Data Science Institute Staff
    SAN DIEGO SUPERCOMPUTER CENTER at UC SAN DIEGO Newsletter innovators JAN | FEB 2018 INSIDE INNOV8@SDSC 2 Welcome from SDSC Director Headlines 3 SDSCers Take the CENIC Route Staff Innovator 4 Meet Kevin Coakley Research 5 SDSC Simulations Advance Heart SDSC Welcomes Halicioğlu Data Drug Design Science Institute Staff Comet Shines in Novel LED Research UC San Diego’s official launch of the year’s announcement of a $75 million Halicioğlu Data Science Institute (HDSI) donation from UC San Diego Alumnus Education in early March was welcomed by SDSC, Taner Halicioğlu (hah-li-jyo-loo) to create 6 REHS Gearing up for Summer! which will house research labs and of- such an institute. SDSC Interns Present at fices for HDSI’s senior staff and faculty “It just made sense to have the institute Biomarkers Conference in the Center’s East Building. “We’re at SDSC because this place is all about pleased that SDSC will be home to many Partnerships data,” said Halicioğlu, who earned a HDSI faculty and staff as this exciting 7 UC San Diego, Japan’s AIST bachelor’s degree in computer science at new initiative gets underway,” said SDSC Expand Alliance the UC San Diego in 1996 and interned Director Michael Norman. “We look for- at SDSC in 1995 and 1996. In remarks San Diego County Funds ward to SDSC being a hub of connectivity during the event, he noted that “data sci- New HPWREN Upgrades for data analytics and innovation for the ence has technically always existed, but entire UC San Diego campus.” Industry Relations I don’t think it really started to coalesce 8 Growing an Innovation Platform UC San Diego Chancellor Pradeep K.
    [Show full text]
  • University of California, San Diego Annual Financial Report 2009–10
    UNIVERSITY OF CALIFORNIA, SAN DIEGO ANNUAL FINANCIAL REPORT 2009–10 UNIVERSITY OF CALIFORNIA, SAN DIEGO ANNUAL FINANCIAL REPORT 2009–10 1 Chancellor Fox Awarded the NATIONAL MEDAL OF SCIENCE UC SAN DIEGO CHANCELLOR MARYE ANNE FOX received the National Medal of Science in 2010, the highest honor bestowed by the United States government on scientists, engineers, and inventors. A nationally recognized organic chemist and academic leader, Fox has been elected to membership in the National Academy of Sciences and the American Philosophical Society, and to fellowships in the American Academy of Arts and Sciences and the American Association for the Advance- ment of Science. She has also received honorary degrees from twelve U.S. institutions. Her research has focused on fundamental principles that were later translated into practical use in solar energy conversion, environmental remediation, and materials science. Fox is the most recent member of the UC San Diego community to receive this prestigious award. Previous living National Medal of Science recipients from UC San Diego are E. Margaret Burbidge, astrophysics (1983); Walter Munk, geophysics (1983); Michael H. Freedman, mathematics (1987); Yuan-Cheng Fung, bioen- gineering (2000); Andrew Viterbi, electrical and computer engineering (2008); and Craig Venter, pharmacology (2009). Clockwise from top: Chancellor Marye Anne Fox; Fox receives the medal from President Barack Obama at the White House, November 17, 2010; an inspirational note Fox wrote as a young girl “I always thought I would be a scientist. Once you’ve understood something that didn’t exist before, it’s almost like you have to figure out what the answer to the next question is, and generate the next question after that.
    [Show full text]
  • Printable UCSD
    D E F G H I J K L M N O e 1 v 1 i r D s n i k p o H To Sorrento Valley Torrey P391–P393 y a Coaster Station J Pines n h o Center J 505 P394 Stuart Collection Torrey North Genesee Avenu Metered Parking Permit Machine Pines e Center V Visitor Parking Change Machine 500 South e n a Accessible Parking L ATM P381–P382 t $ B n $ i Underground “B” Parking o p Spanos A Carpool Parking h A t 2 r Athletic Public Transit Stop 2 o Track e iv N Training and F P383 Facility Dr Field r B B Carpool Parking 525 ente Throwing P352 C Visitor Information Center Field ? P359 cience S Carpool Parking S S N orthpoint Future Facility Dr F Flexcar Parking ive Motorcycle Parking (M Permit Required) 560 ? P358 11/2007 Visitor Genesee North P357 Information Campus Avenu Housing P357 Center e h t Torr r 3 ey Pines o Scenic N North 3 Dr e iv v e i r Campus D P351 s r Recreation a P351 l o h Area c S Ecological e Park v i r Rady School D North s n i of k 561 p o Management Campus H k l a Eleanor 440 W Cafe Ventanas Africa Roosevelt e 430 g 419 d College i Mesa Verde R Salk Institute Road Administration Asia 420 Earth North 441 429 Eleanor428 4 Europe 421 Middle East Geneva 697 696 4 442 451 Roosevelt 453 694 695 Transportation & Parking Services P353 443 P306Institute $ RIMAC Arena 692 College 690 691 693 Latin America Oceania e 455 of the 470 422 Kathmandu Earth South 425 444 P354 North America 426 Americas 423 Cuzco national Lan Harlan 424 r San Diego 445 International Pangea V Inte Supercomputer 645 Relations Frankfurter 681 Parking 435 Asante M o ving in the right dir e c tion.
    [Show full text]
  • Radiation Medicine and Applied Technologies
    University of California San Diego Department of Radiation Medicine and Applied Sciences: Department Overview 2 University of California San Diego University of California System The University of California (UC) http://www.universityofcalifornia.edu was chartered in 1868. As a whole, the UC is one of the largest Universities in the world consisting of over 7,000 faculty members, 160,000 students and employs approximately 121,000 faculty, staff and academics statewide. The UC system is currently comprised of 10 separate campuses: Berkeley, Davis, Irvine, Los Angeles, Merced, Riverside, San Diego, San Francisco, Santa Barbara and Santa Cruz. In 2011, there were over 76,000 student applications. UC is affiliated with the Lawrence Livermore and Lawrence Berkeley Laboratories and the Los Alamos Facility. Each campus boasts a unique environment, and a variety of achievements, honors and academic disciplines. There are 5 medical centers in the UC system: Davis, Irvine, Los Angeles, San Diego and San Francisco. A medical center in Riverside is under development. The 5 UC Medical Centers support the clinical teaching programs of the medical and health sciences schools and receive more than 138,000 inpatient discharges, 261,000 emergency room visits and more than 3.6 million outpatient visits per year. Collectively, these centers comprise the largest health care system in California. University of California San Diego (UCSD) UC San Diego http://www.ucsd.edu/ occupies 1200 acres along the Pacific coast in La Jolla, California. One of the premiere campuses of the UC system, UC San Diego is also one of the youngest (founded in 1960). The first graduate student was admitted in 1960 and the first undergraduate in 1964.
    [Show full text]
  • NR4A Transcription Factors Limit CAR T Cell Function in Solid Tumors
    LETTER https://doi.org/10.1038/s41586-019-0985-x NR4A transcription factors limit CAR T cell function in solid tumours Joyce Chen1,2,3,4*, Isaac F. López-Moyado1,4,5, Hyungseok Seo1, Chan-Wang J. Lio1, Laura J. Hempleman1, Takashi Sekiya6, Akihiko Yoshimura7, James P. Scott-Browne1,4,9,10* & Anjana Rao1,3,4,8,10* T cells expressing chimeric antigen receptors (CAR T cells) targeting CD8+CD45.1+ OT-I cells (specific for chicken ovalbumin (OVA) human CD19 (hCD19) have shown clinical efficacy against B cell SIINFEKL peptide presented by H-2Kb; Extended Data Fig. 2a, b) malignancies1,2. CAR T cells have been less effective against solid showed similar tumour growth rates (Extended Data Fig. 2c); low tumours3–5, in part because they enter a hyporesponsive (‘exhausted’ numbers of CAR T cells were transferred to minimize tumour rejec- or ‘dysfunctional’) state6–9 triggered by chronic antigen stimulation tion (Extended Data Fig. 2d). Eight days after adoptive transfer, CAR and characterized by upregulation of inhibitory receptors and loss of and OT-I tumour-infiltrating lymphocytes (TILs) (Fig. 1b, Extended effector function. To investigate the function of CAR T cells in solid Data Fig. 2b, e, f) comprised around 18% and 9%, respectively, of CD8+ tumours, we transferred hCD19-reactive CAR T cells into hCD19+ TILs (Fig. 1c) and exhibited similar proportions of PD-1hiTIM3hi cells tumour-bearing mice. CD8+CAR+ tumour-infiltrating lymphocytes compared to endogenous TILs (Fig. 1b, Extended Data Fig. 2b). All and CD8+ endogenous tumour-infiltrating lymphocytes expressing TILs produced low levels of TNF and IFNγ upon re-stimulation with the inhibitory receptors PD-1 and TIM3 exhibited similar profiles PMA and ionomycin (Fig.
    [Show full text]
  • 5 24 21 Summary Corona Virus Update by H. Robert Silverstein, MD, FACC for the Preventive Medicine Center
    5 24 21 Summary Corona Virus Update by H. Robert Silverstein, MD, FACC for the Preventive Medicine Center Clyde W. Yancy, MD, Vice Dean for Diversity and Inclusion Chief of Cardiology in the Department of Medicine, Feinberg School of Medicine at Northwestern University in Chicago Clyde W. Yancy, MD: “I’m exhausted by the stress; disheartened by the toll on human life; concerned deeply about the exposure to healthcare workers- BUT, I am emboldened by the display of courage, selflessness, compassion, and sacrifice that I see in physicians, nurses and health care workers across the country.” “It is not a case of ‘don’t confuse me with the facts’, but the best clinical insights exceed so called knowledge by at least one step.” History, precedents, similarities, virus structure and invasion, pathology, physiology, lethality vs safety in perspective, China, geography, EU vs USA comparison, time-line, media, politics, pandemic modelling, symptoms, lockdown, economics, joblessness, vascular-platelet-glycocalyx clotting, testing, ventilators, medications, vaccines, supplements, diet: This 2019 corona virus CoV2-19 is an entirely new RNA virus with 30 proteins. Corona viruses have the largest known viral genome. The RNA of a corona virus is single-stranded. The word 1 “VIRUS” means “poison.” A human cell has 20,000 different proteins. Being an RNA virus, it is similar to hepatitis C; it is not a DNA virus like hepatitis B. There are 200 viruses that can cause the common cold and several of these are corona viruses. “Corona” is Latin for “crown” which is how the virus looks in the microscope as if it has an encircling crown.
    [Show full text]
  • Download Issue
    M A Y 2 0 0 1 Can you believe his eyes or his nose or his smile? Facing the Truth Using Science to Evaluate Expressions Hypertension • DNA’s Machinery • Classroom Design • Molecular Art 18 Touching the Invisible One Molecule at a Time Carlos Bustamante, who took apart toy cars as a boy, is now exploring the machinery of DNA. Cover: Courtesy of Paul Ekman M AY 2 0 0 1 FEATURES VOLUME 14 NUMBER 2 12 Facing the Truth 22 Solving 28 Overcoming the A New Tool to Analyze Hypertension’s Intractable Our Expressions Deadly Puzzle Problem Rick Lifton’s Team at Increasing the Numbers of Yale Is Putting the Pieces Underrepresented Minorities Together in Science 34 N OTA B ENE 2 Awards and Honors 39 Teens Tend to Be Night Owls HHMI TRUSTEES ETTERFROM James A. Baker, III, Esq. L HHMI Awards $15 Million to Senior Partner THE P RESIDENT Baker & Botts European Researchers Alexander G. Bearn, M.D. Executive Officer American Philosophical Society 3 The Other Genome Race Adjunct Professor 40 Untangling the Web of Yeast The Rockefeller University Professor Emeritus of Medicine Protein Interactions Cornell University Medical College Frank William Gay Former President and Chief Executive Officer U P F RONT SUMMA Corporation 41 Vaccination Experiment Casts James H. Gilliam, Jr., Esq. Former Executive Vice President 4 The Human Genome Goes to a Key Guilty Vote Against and General Counsel, Beneficial Corporation Hanna H. Gray, Ph.D., Chairman Amyloid in Alzheimer’s President Emeritus and High School Harry Pratt Judson Distinguished Service Professor of History The University of Chicago 6 Fruit Fly Gene Survey Finds Garnett L.
    [Show full text]
  • Tet2 and Tet3 Cooperate with B-Lineage Transcription Factors To
    RESEARCH ARTICLE Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility Chan-Wang Lio1†, Jiayuan Zhang2†, Edahı´Gonza´ lez-Avalos1, Patrick G Hogan1, Xing Chang1,2,3*, Anjana Rao1,3,4,5* 1Division of Signaling and Gene Expression, San Diego, United States; 2Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3Sanford Consortium for Regenerative Medicine, San Diego, United States; 4Department of Pharmacology, University of California, San Diego, San Diego, United States; 5Moores Cancer Center, University of California, San Diego, San Diego, United States Abstract Ten-eleven translocation (TET) enzymes oxidize 5-methylcytosine, facilitating DNA demethylation and generating new epigenetic marks. Here we show that concomitant loss of Tet2 and Tet3 in mice at early B cell stage blocked the pro- to pre-B cell transition in the bone marrow, decreased Irf4 expression and impaired the germline transcription and rearrangement of the Igk locus. Tet2/3-deficient pro-B cells showed increased CpG methylation at the Igk 3’ and distal enhancers that was mimicked by depletion of E2A or PU.1, as well as a global decrease in chromatin accessibility at enhancers. Importantly, re-expression of the Tet2 catalytic domain in *For correspondence: Tet2/3-deficient B cells resulted in demethylation of the Igk enhancers and restored their chromatin [email protected] (XC); arao@ accessibility. Our data suggest that TET proteins and lineage-specific transcription factors lji.org (AR) cooperate to influence chromatin accessibility and Igk enhancer function by modulating the modification status of DNA.
    [Show full text]